SARS-CoV-2-triggered lymphocytic colitis
- PMID: 34429288
- PMCID: PMC8386217
- DOI: 10.1136/bcr-2021-243003
SARS-CoV-2-triggered lymphocytic colitis
Abstract
The ability of SARS-CoV-2 to infect the gastrointestinal tract is well described. Inflammatory bowel diseases (IBD) are believed to represent a disorganised immune response in genetically predisposed individuals, which are triggered by various environmental factors, notably infections. Here we report a case of chronic watery diarrhoea that was triggered by a SARS-CoV-2 infection. The work-up confirmed a new diagnosis of lymphocytic colitis, and the patient responded favourably to a course of oral budesonide. Clinicians should become vigilant to the possibility of triggered IBD in patients with persistent diarrhoea following a SARS-CoV-2 infection.
Keywords: COVID-19; gastrointestinal system; infection (gastroenterology); inflammatory bowel disease.
© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures



References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous